Risk factors for lymphopenia in patients with relapsing–remitting multiple sclerosis treated with dimethyl fumarate - Morales, Fabian Sierra; Koralnik, Igor J.; Gautam, Shiva; Samaan, Soleil; Sloane, Jacob A. (Journal of neurology, 2020)
Keywords: Adult; Age; Age Factors; Aged; Body Mass Index; Carbamazepine; CD4 antigen; CD8 antigen; Demography; Dimethyl Fumarate - adverse effects; Ethnicity; European Continental Ancestry Group - ethnology; Female; Humans; Immunomodulators; Immunosuppressive Agents - adverse effects; Lymphocyte Count; Lymphocytes; Lymphocytes T; Lymphopenia; Lymphopenia - chemically induced; Male; Medicine; Medicine & Public Health; Middle Aged; Minority & ethnic groups; Monoclonal antibodies; Multiple sclerosis; Multiple Sclerosis, Relapsing-Remitting - drug therapy; Multiple Sclerosis, Relapsing-Remitting - ethnology; Narcotics; Neurology; Neuroradiology; Neurosciences; Opioids; Original Communication; Retrospective Studies; Risk Factors; Smoking; Steroid hormones; Tobacco; Vitamin D; Lymphopenia; Multiple sclerosis; Dimethyl fumarate